(21), which demonstrate that serum IL-6 elevation occurs in rheumatoid arthritis patients receiving TCZ, as TCZ-bound soluble IL-6 receptor impedes IL-6 clearance from circulation. This evidence concerns the gene IL6 and rheumatoid arthritis.